Board of Directors

Mark Tabak has served as Board Director of MultiPlan Parent (or its predecessor) since 2006. Mr. Tabak was Chief Executive Officer of MultiPlan from 2002 to January 2022 and Vice-Chairman and Co-Chief Executive Officer from 2000 to 2002. Prior to that, Mr. Tabak held executive roles at Healthcare Capital Partners, International Management Care Advisors, LLC, American International Group, Inc. (NYSE: AIG), Group Health Plan Inc., Health America and The International Union, United Automobile, Aerospace, and Agricultural Implement Workers of America. Mr. Tabak also served on a commission created to evaluate the impact of various healthcare reform proposals on New York State.

Dale White has served as President and Chief Executive Officer of MultiPlan and as a member of the Board since February 2022 overseeing and executing on the Company’s mission of delivering fairness, efficiency and affordability to the U.S. Healthcare system. Prior to that, Mr. White served as MultiPlan’s President and Chief Operating Officer from August 2021 through February 2022 and in other senior roles at MultiPlan. Before joining MultiPlan in 2004, Mr. White had previously co-founded two healthcare companies and held senior leadership positions at several healthcare organizations, including BCE Emergis where he served as SVP of Sales and Marketing. He also serves on the board of AAPAN, a non-profit trade organization as well as ConvenientMD, a private corporation specializing in urgent care medical services.

Allen R. Thorpe has served as Board Director of MultiPlan Parent (or its predecessor) since June 2016. Mr. Thorpe has served as a Partner of Hellman & Friedman LLC (“Hellman & Friedman”), a private equity firm, since January 2004 and leads the firm’s New York office. Prior to joining Hellman & Friedman in 1999, Mr. Thorpe was a vice president with Pacific Equity Partners in Australia, a private equity firm, and manager at Bain & Company, Inc., a management consulting firm. He currently serves on the board of directors of four private companies: Edelman Financial Engines LLC, Medline Inc., athenahealth and Caliber Collision. Mr. Thorpe also previously served as Chairman of Sheridan Healthcare, Inc., director of PPD, Inc. (NASDAQ: PPD), Change Healthcare Inc. (NASDAQ: CHNG), Mitchell International Inc., Artisan Partners Asset Management Inc. (NYSE: APAM), the lead independent director of LPL Financial Holdings Inc. (NASDAQ: LPLA), and member of the advisory board of Grosvenor Capital Management Holdings, LLP, among others.

Michael K. Attal has served as Board Director of MultiPlan since August 2022. Mr. Attal has served as a Principal at Hellman & Friedman LLC since November 2019. Prior to joining Hellman & Friedman in 2016, Mr. Attal worked as an investment banker in the mergers and acquisitions department of Morgan Stanley & Co.

Glenn R. August has served as a member of our Board since the Churchill’s Initial Public Offering (the “Churchhill IPO”). Mr. August is the Founder and Chief Executive Officer of Oak Hill Advisors, L.P., a leading alternative investment firm. Mr. August serves as global head of the firm's distressed investment activities and chairs or serves on various firm committees. In 2021 T. Rowe Price Group, Inc. acquired Oak Hill Advisors, L.P. and operates it as a standalone business. Since December 2021, Mr. August has been an executive officer and Vice President of T. Rowe Price Group, Inc. and has served on its Management Committee and Board of Directors.

Mr. August co-founded the predecessor investment firm to Oak Hill Advisors, L.P. in 1987 and took responsibility for the firm's credit and distressed investment activities in 1990. He has played leadership roles in numerous restructurings and, since 1987, has served on 18 corporate boards. He currently serves on the Board of Directors of Lucid Group, Inc.(NASDAQ: LCID). Mr. August has served on the Board of Trustees of Horace Mann School since June, 2009 and The Mount Sinai Medical Center since March, 2011. He has also served on the Board of Directors of the Partnership for New York City since January, 2021 and the 92nd Street Y since June, 2002.

Mr. August previously served on the Board of Directors for Cooper Standard Automotive until May 2017 and OHA Investment Corporation until December 2019. He also previously served on the Board of Directors of for Churchill Capital Corporation II (now Skillsoft) until June 2021, Churchill Capital Corporation V until December 2021, Churchill Capital Corporation VI until December2021, and Churchill Capital Corporation VII until December, 2021. He earned an M.B.A. from Harvard Business School, where he was a Baker Scholar, and earned a B.S. from Cornell University.

Richard A. Clarke has served as Board Director of MultiPlan Parent (or its predecessor) since October 2016. Since 2012, Mr. Clarke has served as Chief Executive Officer of Good Harbor Security Risk Management, a private consultancy specializing in cybersecurity for enterprises and mid-cap companies in aviation, insurance, finance, health, technology, and media. He is an advisor at paladin Capital Group (a venture capital firm). In addition, Mr. Clarke is the Chairman of the Board of Governors, Middle East Institute of Washington, D.C. and a member of the Board of Directors of Visible Assets (a private physical security devise manufacturer).

Mr. Clarke served for 30 years in the United States Government, serving three consecutive Presidents. In the White House he served as America’s first “Counter-Terrorism Czar” and its first “Cyber Czar.” Prior to his White House years, he served as a diplomat. He was confirmed as Assistant Secretary of State, and held other positions in the State Department (Deputy Assistant Secretary of State for Intelligence) and the Pentagon for twenty years. Since leaving government in 2003, Mr. Clarke has served as an on-air consultant for ABC News and taught at Harvard’s Kennedy School of Government for five years.

He is the author of ten books, including WARNINGS, on risk management, THE FIFTH DOMAIN, and CYBER WAR on cyber security and AGAINST ALL ENEMIES on terrorism and national security.

Mr. Clarke was co-chair of Virginia Governor McAuliffe’s Cybersecurity Commission and is the Chairman of the Board of Governors, Middle East Institute. He also has served on the New York Cybersecurity Advisory Board since 2013. Mr. Clarke was formerly a member of President Obama’s Review Group on Intelligence and Technology. He has served as a director of several private companies, including Veracode, Inc., Carbon Black, Inc. (f/k/a Bit9, Inc.), Visible Assets, Inc., BlueCat Networks, Inc. and Nok Labs, Inc. He has served on corporate advisory boards including RedSeal, Inc., Paladin Capital Group, Awake Security, Inc., Red Five Security, LLC and HawkEye 360, Inc.

Anthony Colaluca, Jr. has served as Board Director since the closing of the Transactions in October 2020. He has served as the President of AfterNext HealthTech Acquisition Corp., a special purpose acquisition company, since July 2021. He has also served as President of Colaluca Business Advisors, LLC, where he serves as an independent consultant providing business and financial advisory services primarily to private equity firms. From March 2015 to February 2016 he served as Chief Financial Officer and Executive Vice President at MedAssets, Inc., a healthcare performance improvement company. From 2005 through 2010, he served as Chief Financial Officer and Executive Vice President of Intergraph Corporation, a global provider of engineering and geospatial software. Prior to joining Intergraph Corporation, he served as Chief Financial Officer for Harland Financial Solutions, Inc., a software division of John H. Harland Company. Previously, Mr. Colaluca also served as Chief Financial Officer for Novient, Inc./Solution 6 North America, and Chief Financial Officer for Computer Management Sciences Inc., a NASDAQ-listed company that was later acquired by Computer Associates. Earlier in his career, he was a senior manager with KPMG LLP and a certified public accountant in the State of New York. Mr. Colaluca currently serves on the board of directors of AfterNext HealthTech Acquisition Corp and Feeding Northeast Florida. He previously served as a director of Tekelec and member of its audit and compensation committees from February 2011 until the company was taken private in January 2012.

C. Martin Harris has served as Board Director of MultiPlan since January 2021. Dr. Harris has served as Associate Vice President of the Health Enterprise and Chief Business Officer at the Dell Medical School at The University of Texas at Austin since December 2016. Previously, he was CIO and Chairman of the Information Technology Division, as well as a Staff Physician at The Cleveland Clinic Foundation Department of General Internal Medicine. He also served as a Staff Physician for the Cleveland Clinic Hospital. Dr. Harris currently serves on the board of directors of Agiliti (NYSE: AGTI), Thermo Fisher Scientific and Colgate-Palmolive Company and served on the board of directors of HealthStream, Inc. from September 2010 through February 2021.

Julie D. Klapstein has served as Board Director of MultiPlan since November 2020. Ms. Klapstein was the founding Chief Executive Officer of Availity, LLC, a health information network optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. Ms. Klapstein served as Availity’s Chief Executive Officer and board member from 2001 to 2011. She also served as the interim Chief Executive Officer at Medical Reimbursements of America, Inc., a private company, from February 2017 to June 2017. Ms. Klapstein has more than 30 years of experience in the healthcare information technology industry including executive roles at healthcare companies including Phycom, Sunquest Information Systems, SMS’ Turnkey Systems Division and GTE Health Systems. Her early career with AT&T Information Systems also focused on the healthcare industry. Ms. Klapstein currently serves as lead director of Amedisys (NASDAQ: AMED) and is a member of the quality of care, compensation, and nominating and governance committees. She also serves on the board of directors of NextGen Healthcare (NASDAQ: NXGN) and is a member of the audit and compensation committees; Oak Street Health (NYSE: OSH) and is a member of the compliance committee and chair of the compensation committee; and Revecore, a private company.

Michael S. Klein has served as Board Director since the Churchill IPO in February 2020, and previously served as Churchill’s Chief Executive Officer and President from February 2020 to October 2020. Mr. Klein is the designate Chief Executive Officer of Banking and designate Chief Executive Officer of the Americas for Credit Suisse Group, AG, a publically-traded global financial institution (“Credit Suisse), and designate Chief Executive officer of CS First Boston, a carve out of Credit Suisse’s investment banking operation. Mr. Klein is also the Chief Executive Officer and Chairman of Churchill Capital Corp V, Churchill Capital Corp VI and Churchill Capital Corp VII, which are blank check companies whose sponsors are an affiliate of M. Klein & Company, LLC. Mr. Klein also serves on the board of directors of Skillsoft, an entity which merged with Churchill Capital Corp II in June 2021. Prior to the merger, Mr. Klein served as the CEO and Chairman of the board of directors of Churchill Capital Corp II. Mr. Klein is currently a director of Credit Suisse Group AG and Credit Suisse AG, Magic Leap (a private company), TGB Europe NV (a private company), AltC Acquisition Corp. and he holds positions as a board member and/or adviser for multiple charitable organizations. Mr. Klein was the co-founder and Chairman of Churchill Capital Corp, a blank check company formed in 2018. Churchill Capital Corp merged with Clarivate Analytics in May 2019, and Mr. Klein served on the board of directors of Clarivate Analytics through October 2021. Mr. Klein is the founder and managing partner of M. Klein & Company, which he founded in 2012. M. Klein & Company is a global strategic advisory firm that provides its clients a variety of advice tailored to their objectives. Mr. Klein is a strategic advisor to global companies, boards of directors, senior executives, governments and institutional investors. Mr. Klein’s background in strategic advisory work was built during his 30-year career, including more than two decades at Citi and its predecessors, during which he initiated and executed strategic advisory transactions. He began his career as an investment banker in the M&A Advisory Group at Salomon Smith Barney and subsequently became Chairman and Co-Chief Executive Officer of Citi Markets and Banking, with responsibilities for global corporate and investment banking and Global Transaction Services across Citi. 

P. Hunter Philbrick has served as Board Director of MultiPlan Parent (or its predecessor) since June 2016. Mr. Philbrick has served as a Partner at Hellman & Friedman since January 2013. Prior to joining Hellman & Friedman in 2003, Mr. Philbrick worked as an investment banker in the mergers, acquisitions and restructuring and general industrial departments of Morgan Stanley & Co. He currently serves as a member of the board of directors of several private companies, including, Cordis, Vantage Group Holdings, Ltd., and Hub International Limited. Mr. Philbrick was formerly a director of Change Healthcare Inc., a NASDAQ traded company before it was acquired by UnitedHealth in 2022. GeoVera Insurance Holdings Ltd., PPD, Inc. (when it was a publicly traded company) and Sedgwick Inc.